Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
Lebovitz
H E
HE
Downstate Medical Center, Brooklyn, New York 11203.
Vinik
A I
AI
D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000209:etiology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000473:pathology / Q000517:prevention & control*; D003929:Diabetic Neuropathies / Q000473:pathology / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D013453:Sulfonylurea Compounds